Korea Chooses New Group Of Innovators For R&D Support
This article was originally published in PharmAsia News
Executive Summary
South Korea’s Ministry of Health and Welfare has unveiled a list of companies that will be designated as innovative pharma firms for the next three years and thus eligible to receive financial and tax incentives to boost their R&D activities.